Last update 04 Jun 2025

Acellular DTP-Hib combined vaccine(Beijing Luzhu)

Overview

Basic Info

Drug Type
Combination vaccine, Prophylactic vaccine, Conjugated vaccine
Synonyms
组分百白破-Hib四联疫苗
Target-
Action-
Mechanism-
Therapeutic Areas
Infectious DiseasesNervous System DiseasesOtorhinolaryngologic Diseases+ [2]
Active Indication
DiphtheriaEpiglottitisMeningoencephalitis+ [4]
Inactive Indication-
Originator Organization
Beijing Luzhu Biopharmaceutical Co., Ltd.Beijing Luzhu Biopharmaceutical Co., Ltd.
Active Organization
Beijing Luzhu Biopharmaceutical Co., Ltd.Beijing Luzhu Biopharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseIND Approval
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with Acellular DTP-Hib combined vaccine(Beijing Luzhu)
Login to view more data
100 Translational Medicine associated with Acellular DTP-Hib combined vaccine(Beijing Luzhu)
Login to view more data
100 Patents (Medical) associated with Acellular DTP-Hib combined vaccine(Beijing Luzhu)
Login to view more data
100 Deals associated with Acellular DTP-Hib combined vaccine(Beijing Luzhu)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
DiphtheriaIND Approval
China
Beijing Luzhu Biopharmaceutical Co., Ltd.Beijing Luzhu Biopharmaceutical Co., Ltd.
14 May 2025
EpiglottitisIND Approval
China
Beijing Luzhu Biopharmaceutical Co., Ltd.Beijing Luzhu Biopharmaceutical Co., Ltd.
14 May 2025
MeningoencephalitisIND Approval
China
Beijing Luzhu Biopharmaceutical Co., Ltd.Beijing Luzhu Biopharmaceutical Co., Ltd.
14 May 2025
PneumoniaIND Approval
China
Beijing Luzhu Biopharmaceutical Co., Ltd.Beijing Luzhu Biopharmaceutical Co., Ltd.
14 May 2025
SepsisIND Approval
China
Beijing Luzhu Biopharmaceutical Co., Ltd.Beijing Luzhu Biopharmaceutical Co., Ltd.
14 May 2025
TetanusIND Approval
China
Beijing Luzhu Biopharmaceutical Co., Ltd.Beijing Luzhu Biopharmaceutical Co., Ltd.
14 May 2025
Whooping CoughIND Approval
China
Beijing Luzhu Biopharmaceutical Co., Ltd.Beijing Luzhu Biopharmaceutical Co., Ltd.
14 May 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free